familyfortunesquestions|信达生物(01801.HK)授出3371份购股权及9551股受限制股份

Gelonghui May 3 丨 Cinda Biotech (01801familyfortunesquestions.HK) AnnouncementfamilyfortunesquestionsOn May 3, 2024, the Company granted 3371 share options to Chen Shuyun, an independent non-executive director, in accordance with the terms of the post-IPO employee shareholding plan, subject to Chen's acceptance. The Board of Directors announced that on May 3, 2024, the Company granted 9551 restricted shares to Chen Shuyun under the 2020 Restricted Share Plan, subject to Chen's acceptance and approval by independent shareholders at the annual general meeting.